1例重症COVID-19康复后可逆性混合性心肌病病例报告

O. Shakhmatova, E. Panchenko, N. Y. Mironov, O. V. Stukalova, T. Balakhonova, M. Makeev
{"title":"1例重症COVID-19康复后可逆性混合性心肌病病例报告","authors":"O. Shakhmatova, E. Panchenko, N. Y. Mironov, O. V. Stukalova, T. Balakhonova, M. Makeev","doi":"10.17116/cardiobulletin20231801180","DOIUrl":null,"url":null,"abstract":"We present reversible cardiomyopathy in a patient recovered from severe COVID-19. In addition to heart failure, the patient had thrombosis of abdominal aorta, lower extremity arteries and kidney infarction. At admission, the left ventricular ejection fraction (LVEF) was 18%. Primary diagnosis was SARSCoV2-induced myocarditis. However, cardiac MRI with delayed gadolinium enhancement revealed no fibrosis or active myocarditis. Troponin was normal. Atrial fibrillation persisted. Arrhythmia was first verified a week before COVID-19. Previously effective treatment failed to support adequate heart rate after COVID-19. Angiography revealed subtotal stenosis of the left anterior descending artery. After strict rate control and percutaneous coronary intervention, the patient was discharged on optimal medical therapy. Six months later, LVEF was 45%. Pulmonary vein isolation and cardioversion were performed. One week later, LVEF was 60%. In our opinion, this was a mixed cardiomyopathy with predominant role of AF and myocardial ischemia. Probably, COVID-19 modulated natural course of cardiovascular pathology. We also discuss potential contribution of COVID-19 to the course of cardiovascular pathology in long-term period of disease. © 2023, Media Sphera Publishing Group. All rights reserved.","PeriodicalId":305396,"journal":{"name":"Kardiologicheskii vestnik","volume":"181 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reversible mixed cardiomyopathy in a patient recovered from severe COVID-19: a case report\",\"authors\":\"O. Shakhmatova, E. Panchenko, N. Y. Mironov, O. V. Stukalova, T. Balakhonova, M. Makeev\",\"doi\":\"10.17116/cardiobulletin20231801180\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We present reversible cardiomyopathy in a patient recovered from severe COVID-19. In addition to heart failure, the patient had thrombosis of abdominal aorta, lower extremity arteries and kidney infarction. At admission, the left ventricular ejection fraction (LVEF) was 18%. Primary diagnosis was SARSCoV2-induced myocarditis. However, cardiac MRI with delayed gadolinium enhancement revealed no fibrosis or active myocarditis. Troponin was normal. Atrial fibrillation persisted. Arrhythmia was first verified a week before COVID-19. Previously effective treatment failed to support adequate heart rate after COVID-19. Angiography revealed subtotal stenosis of the left anterior descending artery. After strict rate control and percutaneous coronary intervention, the patient was discharged on optimal medical therapy. Six months later, LVEF was 45%. Pulmonary vein isolation and cardioversion were performed. One week later, LVEF was 60%. In our opinion, this was a mixed cardiomyopathy with predominant role of AF and myocardial ischemia. Probably, COVID-19 modulated natural course of cardiovascular pathology. We also discuss potential contribution of COVID-19 to the course of cardiovascular pathology in long-term period of disease. © 2023, Media Sphera Publishing Group. All rights reserved.\",\"PeriodicalId\":305396,\"journal\":{\"name\":\"Kardiologicheskii vestnik\",\"volume\":\"181 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kardiologicheskii vestnik\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17116/cardiobulletin20231801180\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologicheskii vestnik","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/cardiobulletin20231801180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

我们报告了一例从严重COVID-19康复的患者的可逆性心肌病。除心力衰竭外,患者有腹主动脉、下肢动脉血栓形成及肾梗死。入院时左室射血分数(LVEF)为18%。初步诊断为sarscov2性心肌炎。然而,心脏MRI延迟钆增强显示没有纤维化或活动性心肌炎。肌钙蛋白正常。房颤持续存在。在COVID-19前一周首次确诊心律失常。先前有效的治疗无法支持COVID-19后适当的心率。血管造影显示左前降支近全狭窄。经过严格的率控制和经皮冠状动脉介入治疗,患者在最佳药物治疗下出院。6个月后,LVEF为45%。进行肺静脉隔离和心肺复律。一周后,LVEF为60%。我们认为,这是一种以房颤和心肌缺血为主的混合性心肌病。可能是COVID-19调节了心血管病理的自然过程。我们还讨论了COVID-19在长期疾病期间对心血管病理过程的潜在贡献。©2023,Media Sphera出版集团。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Reversible mixed cardiomyopathy in a patient recovered from severe COVID-19: a case report
We present reversible cardiomyopathy in a patient recovered from severe COVID-19. In addition to heart failure, the patient had thrombosis of abdominal aorta, lower extremity arteries and kidney infarction. At admission, the left ventricular ejection fraction (LVEF) was 18%. Primary diagnosis was SARSCoV2-induced myocarditis. However, cardiac MRI with delayed gadolinium enhancement revealed no fibrosis or active myocarditis. Troponin was normal. Atrial fibrillation persisted. Arrhythmia was first verified a week before COVID-19. Previously effective treatment failed to support adequate heart rate after COVID-19. Angiography revealed subtotal stenosis of the left anterior descending artery. After strict rate control and percutaneous coronary intervention, the patient was discharged on optimal medical therapy. Six months later, LVEF was 45%. Pulmonary vein isolation and cardioversion were performed. One week later, LVEF was 60%. In our opinion, this was a mixed cardiomyopathy with predominant role of AF and myocardial ischemia. Probably, COVID-19 modulated natural course of cardiovascular pathology. We also discuss potential contribution of COVID-19 to the course of cardiovascular pathology in long-term period of disease. © 2023, Media Sphera Publishing Group. All rights reserved.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Transit time flow measurement in patients with diffuse coronary artery disease during coronary artery bypass grafting Features of the course and approaches to the treatment of coronavirus infection COVID- 19 patients with cardiovascular diseases Combined open and hybrid interventions in the coronary and internal carotid arteries - search for the perfect approach Pulmonary veins isolation with left atrial appendage closure of non-valvular atrial fibrillation Peripheral arterial diseases and the risk of thrombotic outcomes in patients after scheduled percutaneous coronary interventions (according to results of prospective study)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1